DEVELOPMENT AND OPTIMIZATION OF ASTRAGALIN-LOADED POLYMERIC NANOPARTICLES USING CENTRAL COMPOSITE FACTORIAL DESIGN

S. KALIDAS; P. GEETHA

doi:10.22159/ijap.2022v14i5.44315

Authors

S. KALIDAS Vels Institute of Science, Technology and Advanced Studies (VISTAS), School of Pharmaceutical Sciences, Chennai 600117, India
P. GEETHA Vels Institute of Science, Technology and Advanced Studies (VISTAS), School of Pharmaceutical Sciences, Chennai 600117, India

DOI:

https://doi.org/10.22159/ijap.2022v14i5.44315

Keywords:

Polymeric nanoparticles, Central composite factorial design, In vitro release, Percentage entrapment efficiency

Abstract

Objective: The objective of the present study was to develop and optimize Astragalin-loaded polymeric nanoparticles (AST-NPs) using a central composite factorial design (CCD).

Methods: AST-NPs were prepared by the dialysis method. CCD was employed to study the influence of formulation factors, polymer concentration, aqueous organic phase ratio, and process parameter stirring time on dependent physicochemical characteristics, particle size, zeta potential, and percentage entrapment efficiency (%EE) of the drugs. The optimized formulation was evaluated for in vitro release studies and subjected to stability studies.

Results: Polymer concentration and process parameters were optimized to produce nanoparticles with desired parameters. The prepared NPs were characterized by Fourier transmission infrared (FT-IR), differential scanning calorimetry (DSC), drug loading, entrapment efficiency, particle size, zeta potential, and in vitro studies. FT-IR and DSC studies indicated that there was no interaction between the drug and polymer. The optimized NPs exhibits stability. Optimized NPs exhibited spherical and porous surfaces with a mean PS of 118 nm, the zeta potential of-25 mV, and %EE of 89%.

Conclusion: Astragalin-loaded nanoparticles prepared with optimized formulation composition and process parameters.

Downloads

Download data is not yet available.

Author Biographies

S. KALIDAS, Vels Institute of Science, Technology and Advanced Studies (VISTAS), School of Pharmaceutical Sciences, Chennai 600117, India

Research Scholar, Vels Institute of Science, Technology and Advanced Studies (VISTAS), School of Pharmaceutical Sciences, Chennai-600117, India.

P. GEETHA, Vels Institute of Science, Technology and Advanced Studies (VISTAS), School of Pharmaceutical Sciences, Chennai 600117, India

Assistant Professor, Vels Institute of Science, Technology and Advanced Studies (VISTAS), School of Pharmaceutical Sciences, Chennai-600117, India.

References

Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75(3):311-35. doi: 10.1021/np200906s, PMID 22316239.

Riaz A, Rasul A, Hussain G, Zahoor MK, Jabeen F, Subhani Z. Astragalin: A bioactive phytochemical with potential therapeutic activities. Adv Pharmacol Sci. 2018;2018:9794625. doi: 10.1155/2018/9794625, PMID 29853868.

Mehdi A, Al-Ani WMK, Raoof A. Isolation of astragalin from iraqi chenopodium album. Asian J Pharm Clin Res. 2018;11(12):530-5. doi: 10.22159/ajpcr.2018.v11i12.27958.

Kotani M, Matsumoto M, Fujita A, Higa S, Wang W, Suemura M. Persimmon leaf extract and astragalin inhibit the development of dermatitis and IgE elevation in NC/Nga mice. J Allergy Clin Immunol. 2000;106:159-66. doi: 10.1067/mai.2000.107194, PMID 10887319.

Bitis L, Kultur S, Melikoglu G, Ozsoy N, Can A. Flavonoids and antioxidant activity of rosa agrestis leaves. Nat Prod Res. 2010;24(6):580-9. doi: 10.1080/14786410903075507, PMID 20397108.

Kim YH, Choi YJ, Kang MK, Park SH, Antika LD, Lee EJ. Astragalin inhibits allergic inflammation and airway thickening in ovalbumin-challenged mice. J Agric Food Chem. 2017;65(4):836-45. doi: 10.1021/acs.jafc.6b05160, PMID 28064485.

Burmistrova O, Quintana J, Díaz JG, Estevez F. Astragalin heptaacetate-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathway. Cancer Lett. 2011;309(1):71-7. doi: 10.1016/j.canlet.2011.05.018, PMID 21658841.

Bainey KR, Armstrong PW. Clinical perspectives on reperfusion injury in acute myocardial infarction. Am Heart J. 2014;167(5):637-45. doi: 10.1016/j.ahj.2014.01.015, PMID 24766972.

Pathak S, Vyas SP, Pandey A. Development, characterization, and in vitro release kinetic studies of ibandronate loaded chitosan nanoparticles for effective management of osteoporosis. Int J Appl Pharm. 2021;13(6):120-5.

El-Assal MI, Samuel D. Optimization of rivastigmine chitosan nanoparticles for neurodegenerative Alzheimer; in vitro and ex vivo characterizations. Int J Pharm Pharm Sci. 2021;14(1):17-27. doi: 10.22159/ijpps.2022v14i1.43145.

Esfanjani AF, Seid Mahdi Jafari. Biopolymer nanoparticles and natural nanocarriers for nano-encapsulation of phenolic compounds. Colloids and Surfaces B: Biointerfaces; 2016. doi: 10.1016/j.colsurfb.2016.06.053.

Couvreur P, Dubernet C, Puisieux F. Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur J Pharm Biopharm. 1995:2-13.

Kreuter J. Colloidal drug delivery systems. CRC Press; 1994.

Nah JW, Paek YW, Jeong YI, Kim DW, Cho CS, Kim SH. Clonazepam release from poly(DL-lactide-co-glycolide) nanoparticles prepared by dialysis method. Arch Pharm Res. 1998;21(4):418-22. doi: 10.1007/BF02974636, PMID 9875469.

Das J, Debbarma A, Lalhlenmawia. Formulation and in vitro evaluation of poly(d, l-lactide-co-glycolide) (plga) nanoparticles of ellagic acid and its effect on human breast cancer, mcf-7 cell line. Int J Curr Pharm Res. 2021;13(5):56-62.

Barhoum A, Garcia Betancourt ML, Rahier H, Assche GV. Physicochemical characterization of nanomaterials: polymorph, composition, wettability, and thermal stability. In: Emerging applications of nanoparticles and architecture nanostructures current prospects and future trends micro and Nanotechnologies. Acdemia Press; 2018. p. 255-78.

Koshy O, Subramanian L, Thomas S, Chapter 5. Differential scanning calorimetry in nanoscience and nanotechnology. In: Thomas S, Thomas Raju, Zachariah AK, Mishra RK, editors, Micro and nano technologies, thermal and rheological measurement techniques for nanomaterials characterization. Elsevier; 2017. p. 109-22.

Ma Y, Zheng Y, Liu K, Tian G, Tian Y, Xu L. Nanoparticles of poly(Lactide-Co-Glycolide)-d-a-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatment. Nanoscale Res Lett. 2010;5(7):1161-9. doi: 10.1007/s11671-010-9620-3, PMID 20596457.

Liu J, Huang Y, Kumar A, Tan A, Jin S, Mozhi A. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv. 2014;32(4):693-710. doi: 10.1016/j.biotechadv.2013.11.009, PMID 24309541.